2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$5.94-$0.09 (-1.56%)
Price as of Nov 12, 2026 7:57 AM EST- $85.6MMarket Cap
- 131.92%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$5.94-$0.09 (-1.56%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.03 | ||
Change | -$0.22 (-3.52%) | ||
Open | $6.26 | ||
High | $6.43 | ||
Low | $6.00 | ||
Previous Close | $6.25 | ||
Volume | 202,914 | ||
30-Day Average Volume | 164,808 | ||
1-Week Change | -12.10% | ||
1-Month Change | -12.99% | ||
1-Year Change | 131.92% | ||
3-Year Change | 136.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.2M | ||
Total Assets | $6.7M | ||
Market Cap | $85.6M | ||
Enterprise Value | $81.5M | ||
Period: QTR TTM FY | |||
Revenue | $2.0M | ||
Net Income | -$6.5M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$6.5M | ||
EBITDA | -$6.5M | ||
Net Working Capital | $3.2M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 40 | ||
P/B | 24 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue